Alto Neuroscience ANRO Proceeds From Long Term Lines Of Credit
Proceeds From Long Term Lines Of Credit at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromLongTermLinesOfCredit.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's proceeds from long term lines of credit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's proceeds from long term lines of credit?
- Alto Neuroscience (ANRO) reported proceeds from long term lines of credit of $0 in Q1 2026.
- What does proceeds from long term lines of credit mean?
- Captures cash inflows derived from drawing down on long-term debt facilities or credit lines. This metric indicates the company's reliance on debt financing to supplement cash reserves for operational or strategic needs. It provides insight into the company's debt capacity and liquidity management strategy.